SEATTLE (AP) _ Omeros Corporation (OMER) on Monday reported a loss of $38.5 million in its third quarter.

On a per-share basis, the Seattle-based company said it had a loss of 66 cents. Losses, adjusted for one-time gains and costs, were 34 cents per share.

The drug developer posted revenue of $26.1 million in the period.

Omeros shares have dropped 22% since the beginning of the year. In the final minutes of trading on Monday, shares hit $10.99, a decrease of 19% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News